News

Events

Kytopen to exhibit at BPI's Biotech Week Boston

Please visit us at Booth 300 at the Cell & Gene Therapy Manufacturing & Commercialization part of...
Kytopen
September 21, 2022
Events

Kytopen to exhibit at Advanced Therapies Week in Miami Jan. 25th – 28th.

Please visit us at Booth 635 to see a demonstration of our Flowfect® Tx for cGMP-compliant cell...
Kytopen
January 14, 2022
Partners

On a Journey to Drastically Speed Up Cell Therapy Manufacturing, Kytopen Lands $30M Series A

Spun out of an MIT lab, sitting in an office space above a Cambridge tapas restaurant from...
Kytopen
October 04, 2021
Partners

MIT Cell-Engineering Spinout Nets $30M for Mass Manufacturing Platform

One of the tricks of getting cell therapies to work is getting the payload you want into the cell...
Kytopen
September 29, 2021
Partners

Stem-cell Start-ups Seek to Crack the Mass-Production Problem

In the laboratory, induced pluripotent stem (iPS) cells can seem like magic: derived from...
Kytopen
September 29, 2021
Partners

Kytopen Raises $30M in Series A Funding, Led by Northpond Ventures, to Transform Non-Viral Delivery via the Flowfect Platform

Financing will accelerate momentum toward unlocking the linearity between discovery and...
Kytopen
September 28, 2021
Technology

Kytopen awarded NIH grant of up to $2M to unlock the power of engineered Natural Killer (NK) cells via Flowfect® platform

NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral...
Kytopen
June 15, 2021
Publications

Kytopen presents at Cellicon Valley 2021

The 2021 Cellicon Valley Symposium is presented by Penn’s Abramson Cancer Center and Children’s...
Kytopen
April 30, 2021